Joel R. Gever

Pharmacological pleiotropism of the human recombinant <i>α</i>_1A‐adrenoceptor: implications for <i>α</i>₁‐adrenoceptor classification

Anthony Ford, Donald V. Daniels, David J. Chang et al. · British Journal of Pharmacology · 1997 · 220 citations · Full text

Medicine, Biochemistry, Pharmacology +6

2-Aminothiazoles as Therapeutic Leads for Prion Diseases

Alejandra Gallardo‐Godoy, Joel R. Gever, Kimberly L. Fife et al. · Journal of Medicinal Chemistry · 2011 · 140 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist

Joel R. Gever, Rothschild Soto, Robert Henningsen et al. · British Journal of Pharmacology · 2010 · 130 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists

Keith Bley, Anindya Bhattacharya, Don V Daniels et al. · British Journal of Pharmacology · 2005 · 96 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

Action of MK‐7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation

David M. Richards, Joel R. Gever, Anthony Ford et al. · British Journal of Pharmacology · 2019 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17